Claims for Patent: 9,296,782

Summary for Patent: 9,296,782

Title:	Inhibitors of hepatitis C virus
Abstract:	Compounds of Formula I are disclosed ##STR00001## As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
Inventor(s):	Bjornson; Kyla (San Lorenzo, CA), Canales; Eda (San Mateo, CA), Cottell; Jeromy J. (Redwood City, CA), Karki; Kapil Kumar (Foster City, CA), Katana; Ashley Anne (San Mateo, CA), Kato; Darryl (San Francisco, CA), Kobayashi; Tetsuya (Sunnyvale, CA), Link; John O. (San Francisco, CA), Martinez; Ruben (South San Francisco, CA), Phillips; Barton W. (San Mateo, CA), Pyun; Hyung-Jung (Fremont, CA), Sangi; Michael (Oakland, CA), Schrier; Adam James (Redwood City, CA), Siegel; Dustin (Foster City, CA), Taylor; James G. (San Mateo, CA), Tran; Chinh Viet (San Diego, CA), Trejo Martin; Teresa Alejandra (Union City, CA), Vivian; Randall W. (San Mateo, CA), Yang; Zheng-Yu (Palo Alto, CA), Zablocki; Jeff (Los Altos, CA), Zipfel; Sheila (San Mateo, CA)
Assignee:	Gilead Sciences, Inc. (Foster City, CA)
Application Number:	13/934,090
Patent Claims:	1. A compound of Formula lVa: ##STR00672## or a pharmaceutically acceptable salt thereof. 2. A compound of claim 1 which is: ##STR00673## or a pharmaceutically acceptable salt thereof. 3. A compound of Formula lVc: ##STR00674## or a pharmaceutically acceptable salt thereof. 4. A compound of claim 3 which is: ##STR00675## or a pharmaceutically acceptable salt thereof. 5. A compound of Formula lVe: ##STR00676## or a pharmaceutically acceptable salt thereof. 6. A compound of claim 5 which is: ##STR00677## or a pharmaceutically acceptable salt thereof. 7. A compound of formula lVg: ##STR00678## or a pharmaceutically acceptable salt thereof. 8. A compound of claim 7 which is: ##STR00679## or a pharmaceutically acceptable salt thereof. 9. A compound which is: ##STR00680## 10. A composition comprising the compound of claim 9 and a pharmaceutically acceptable carrier. 11. A compound which is: ##STR00681## 12. A composition comprising the compound of claim 11 and a pharmaceutically acceptable carrier. 13. A compound which is: ##STR00682## 14. A composition comprising the compound of claim 13 and a pharmaceutically acceptable carrier. 15. A compound which is: ##STR00683## 16. A composition comprising the compound of claim 15 and a pharmaceutically acceptable carrier.